Micro- and nanoplastics (MNPs) have rapidly become one of the most high-profile topics in environmental health. But with that visibility has come scrutiny. Fazel A. Monikh and colleagues have challenged widely publicized findings that suggest significant accumulation of plastics in the human brain, pointing to methodological gaps, limited contamination controls, and a lack of validated analytical frameworks.
Here, Monikh reflects on what prompted the response, the importance of physical plausibility, and what the microplastics debate reveals about modern science.
What prompted you to write this Matters Arising piece?
The field has gained strong momentum, and many papers are published every week. My concern is that non-robust data may harm not only scientific progress and industry, but also public trust in policymaking and risk assessment. This paper received a lot of visibility, yet the underlying analytical evidence was not sufficiently robust. That is why I decided to respond.
There was also a more immediate signal. I noticed that students reading these papers were developing questions and hypotheses that did not align with basic biological and analytical logic. This showed how easily weak or uncertain findings can shape scientific thinking, especially among early-career researchers.
You’ve raised the question of physical plausibility. Could you expand on that?
If the reported data were correct, it would imply that the brain accumulates far more plastic than other organs such as the liver. This contradicts fundamental biological knowledge, since the brain is protected by selective barriers like the blood-brain barrier.
It is also implausible that only one polymer type would accumulate so extensively while others do not. When you translate the reported concentrations into particle numbers, you arrive at extraordinarily high values – on the order of trillions of particles per gram of tissue – which raises serious questions about physical feasibility. Such findings require careful analytical scrutiny.
Do you see this study as an isolated case, or part of a broader pattern?
It reflects a broader pattern in a rapidly expanding field, where analytical robustness does not always keep pace with publication speed. This makes careful evaluation and validation even more important.
Is this fundamentally a microplastics problem, or something larger about how science behaves when a topic becomes “hot”?
Microplastics may have important health effects, and the topic deserves serious investigation. However, this is also a broader issue affecting rapidly growing fields, where analytical challenges and publication pressure can lead to premature conclusions.
One major factor is the lack of suitable and fully validated analytical methods, especially for complex biological samples. This makes reliable detection and interpretation difficult.
What does this episode tell us about the role of analytical science?
It highlights that analytical science is central to the credibility of the microplastics field. Sample preparation, contamination control, and method validation are essential, yet their importance is sometimes underestimated outside analytical disciplines.
Who should bear responsibility for maintaining high analytical standards in emerging, high-impact areas?
It is a shared responsibility. Individual laboratories, journals, reviewers, funders, and the broader scientific community must all contribute to maintaining analytical rigor and transparency.
Independent analytical evaluation of high-visibility studies could help identify limitations early and improve the overall robustness and reliability of the field.
You’ve suggested the field may be moving faster than the tools available. What capabilities are missing?
We need validated and standardized protocols, certified reference materials, and analytical workflows that combine multiple complementary methods. These are essential for reliable biomonitoring.
How concerned are you about premature findings shaping policy or public perception?
This is a real concern. Policy and public perception depend on scientific evidence, and if that evidence is not robust, it can lead to ineffective or misguided decisions.
What conversations do you hope this work sparks?
I hope it encourages more careful discussion about analytical rigor, method validation, and physical plausibility, so that the field develops on a scientifically sound foundation.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
